Wikidata

(Q61692534)

English

Bevacizumab (B) plus low-doses immunotherapy (IT) plus chemotherapy (CT) (BIC) in metastatic renal cell cancer (mRCC): Antitumor effects and variations of T-regulatory cells (Treg) and other T lymphocytes subsets. A study of the Italian Oncology Grou

article

In more languages

Statements

title
Bevacizumab (B) plus low-doses immunotherapy (IT) plus chemotherapy (CT) (BIC) in metastatic renal cell cancer (mRCC): Antitumor effects and variations of T-regulatory cells (Treg) and other T lymphocytes subsets. A study of the Italian Oncology Grou (English)
0 references
author name string
R. Passalacqua
series ordinal
1
0 references
S. Buti
series ordinal
2
0 references
L. Rivoltini
series ordinal
3
0 references
C. Castelli
series ordinal
4
0 references
C. Camisaschi
series ordinal
5
0 references
C. Simonelli
series ordinal
6
0 references
G. Lo Re
series ordinal
7
0 references
R. Mattioli
series ordinal
8
0 references
G. Mazza
series ordinal
9
0 references
M. Brighenti
series ordinal
10
0 references
S. Lazzarelli
series ordinal
11
0 references
publication date
20 May 2008
0 references
volume
26
0 references
issue
15_suppl
0 references
page(s)
5121-5121
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61692534&oldid=1955660993"